Cancer vaccine NY-ESO-1 (Ludwig Institute/Peking University/Jewim Pharmaceutical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCancer vaccine NY-ESO-1 (Ludwig Institute/Peking University/Jewim Pharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCancer/testis antigen 1 modulators
TargetsCancer/testis antigen 1
Therapy Area/IndicationsLiver NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLudwig Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesLudwig Institute For Cancer ResearchPeking University
Inactive CompaniesN/A
Active IndicationsLiver NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A